/

Usuario:

1.2.1.3 Libro Científico

Por favor, utilice la liga Insertar nuevo registro para agregar registros, la liga Ver para verificar los datos, si se requiere algún cambio, presione la liga Editar; en caso de querer eliminar toda la información del registro, presione la liga Borrar. Al final presione el botón Aceptar o Confirmar para registrar los cambios

Página anterior Registro anterior Registro siguiente



Nombre del Modulo  1.2.1.3 Libro científico
Titulo  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Subtitulo  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Colección  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Número de Páginas  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Edición  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
ISBN  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Pais  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Idioma  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Editorial  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Tiraje  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Fecha de Aceptación  0000-00-00
Fecha de Publicación  0000-00-00
Coautores  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Año de la Actividad  2007
Observaciones  The manager http://9taxi.in.net/ 9taxi It was approved on the heels of two other new blood clotpreventers that have become blockbuster products, Pradaxa fromBoehringer Ingelheim and Xarelto from Johnson & Johnson and Bayer AG. Xarelto is favored by many
Proyecto de Investigacion Asignado